Clinical comparison of hearing-impaired patients with DFNB1 against heterozygote carriers of connexin 26 mutations

Michael Lipan, Xiaomei Ouyang, Denise Yan, Simon I Angeli, Li Lin Du, Xue Z Liu

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Objectives: The aim of the study is to assess clinical characteristics of individuals with nonsyndromic sensorineural hearing loss (NSSNHL) with genetic mutations in GJB2 and/or GJB6. We describe and compare one group with biallelic mutations against a group of heterozygote mutation carriers. Methods: A total of 350 patients between the ages of 3 months and 80 years referred to a tertiary care outpatient otology practice for NSSNHL were screened for genetic mutations. Direct sequencing of GJB2 and polymerase chain reaction analysis of GJB6 was performed and clinical data from history and physical, audiologic testing and radiographic studies were reviewed. Results: Thirty-two patients were found to have biallelic mutations (incidence of 9.1%). Twenty-five patients were found to have only one GJB2 mutation (incidence of 7.1%). Severe to profound hearing loss occurred in 85% of the homozygote group and 38% of the heterozygote group. Both groups similarly had a propensity toward bilateral, symmetric, nonprogressive hearing loss with rare inner ear malformations on radiologic imaging. Conclusions: These two patient populations have similar incidences in a cohort of patients evaluated for NSSNHL, which is higher than general population heterozygote carrier rates. Heterozygote mutation carriers had less hearing impairment, but most other factors demonstrated no differences. These results support the theory of an unidentified genetic factor contributing to hearing loss in some heterozygote carriers. Therefore, genetic counseling should consider the complexity of their genetic factors and the limitations of current screening.

Original languageEnglish
Pages (from-to)811-814
Number of pages4
JournalLaryngoscope
Volume121
Issue number4
DOIs
StatePublished - Apr 1 2011

Fingerprint

Heterozygote
Hearing
Mutation
Hearing Loss
Incidence
Genetic Counseling
Otolaryngology
Homozygote
Inner Ear
Tertiary Healthcare
Connexin 26
Population
Outpatients
History
Polymerase Chain Reaction
Nonsyndromic sensorineural hearing loss

Keywords

  • cochlear implant
  • computed tomography
  • Connexin 26
  • connexin 30
  • DFNB1
  • GJB2
  • GJB6
  • molecular genetic testing.
  • nonsyndromic sensorineural hearing loss

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Clinical comparison of hearing-impaired patients with DFNB1 against heterozygote carriers of connexin 26 mutations. / Lipan, Michael; Ouyang, Xiaomei; Yan, Denise; Angeli, Simon I; Du, Li Lin; Liu, Xue Z.

In: Laryngoscope, Vol. 121, No. 4, 01.04.2011, p. 811-814.

Research output: Contribution to journalArticle

@article{1a41f156a80445fd8eca8ebe224fdb40,
title = "Clinical comparison of hearing-impaired patients with DFNB1 against heterozygote carriers of connexin 26 mutations",
abstract = "Objectives: The aim of the study is to assess clinical characteristics of individuals with nonsyndromic sensorineural hearing loss (NSSNHL) with genetic mutations in GJB2 and/or GJB6. We describe and compare one group with biallelic mutations against a group of heterozygote mutation carriers. Methods: A total of 350 patients between the ages of 3 months and 80 years referred to a tertiary care outpatient otology practice for NSSNHL were screened for genetic mutations. Direct sequencing of GJB2 and polymerase chain reaction analysis of GJB6 was performed and clinical data from history and physical, audiologic testing and radiographic studies were reviewed. Results: Thirty-two patients were found to have biallelic mutations (incidence of 9.1{\%}). Twenty-five patients were found to have only one GJB2 mutation (incidence of 7.1{\%}). Severe to profound hearing loss occurred in 85{\%} of the homozygote group and 38{\%} of the heterozygote group. Both groups similarly had a propensity toward bilateral, symmetric, nonprogressive hearing loss with rare inner ear malformations on radiologic imaging. Conclusions: These two patient populations have similar incidences in a cohort of patients evaluated for NSSNHL, which is higher than general population heterozygote carrier rates. Heterozygote mutation carriers had less hearing impairment, but most other factors demonstrated no differences. These results support the theory of an unidentified genetic factor contributing to hearing loss in some heterozygote carriers. Therefore, genetic counseling should consider the complexity of their genetic factors and the limitations of current screening.",
keywords = "cochlear implant, computed tomography, Connexin 26, connexin 30, DFNB1, GJB2, GJB6, molecular genetic testing., nonsyndromic sensorineural hearing loss",
author = "Michael Lipan and Xiaomei Ouyang and Denise Yan and Angeli, {Simon I} and Du, {Li Lin} and Liu, {Xue Z}",
year = "2011",
month = "4",
day = "1",
doi = "10.1002/lary.21422",
language = "English",
volume = "121",
pages = "811--814",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Clinical comparison of hearing-impaired patients with DFNB1 against heterozygote carriers of connexin 26 mutations

AU - Lipan, Michael

AU - Ouyang, Xiaomei

AU - Yan, Denise

AU - Angeli, Simon I

AU - Du, Li Lin

AU - Liu, Xue Z

PY - 2011/4/1

Y1 - 2011/4/1

N2 - Objectives: The aim of the study is to assess clinical characteristics of individuals with nonsyndromic sensorineural hearing loss (NSSNHL) with genetic mutations in GJB2 and/or GJB6. We describe and compare one group with biallelic mutations against a group of heterozygote mutation carriers. Methods: A total of 350 patients between the ages of 3 months and 80 years referred to a tertiary care outpatient otology practice for NSSNHL were screened for genetic mutations. Direct sequencing of GJB2 and polymerase chain reaction analysis of GJB6 was performed and clinical data from history and physical, audiologic testing and radiographic studies were reviewed. Results: Thirty-two patients were found to have biallelic mutations (incidence of 9.1%). Twenty-five patients were found to have only one GJB2 mutation (incidence of 7.1%). Severe to profound hearing loss occurred in 85% of the homozygote group and 38% of the heterozygote group. Both groups similarly had a propensity toward bilateral, symmetric, nonprogressive hearing loss with rare inner ear malformations on radiologic imaging. Conclusions: These two patient populations have similar incidences in a cohort of patients evaluated for NSSNHL, which is higher than general population heterozygote carrier rates. Heterozygote mutation carriers had less hearing impairment, but most other factors demonstrated no differences. These results support the theory of an unidentified genetic factor contributing to hearing loss in some heterozygote carriers. Therefore, genetic counseling should consider the complexity of their genetic factors and the limitations of current screening.

AB - Objectives: The aim of the study is to assess clinical characteristics of individuals with nonsyndromic sensorineural hearing loss (NSSNHL) with genetic mutations in GJB2 and/or GJB6. We describe and compare one group with biallelic mutations against a group of heterozygote mutation carriers. Methods: A total of 350 patients between the ages of 3 months and 80 years referred to a tertiary care outpatient otology practice for NSSNHL were screened for genetic mutations. Direct sequencing of GJB2 and polymerase chain reaction analysis of GJB6 was performed and clinical data from history and physical, audiologic testing and radiographic studies were reviewed. Results: Thirty-two patients were found to have biallelic mutations (incidence of 9.1%). Twenty-five patients were found to have only one GJB2 mutation (incidence of 7.1%). Severe to profound hearing loss occurred in 85% of the homozygote group and 38% of the heterozygote group. Both groups similarly had a propensity toward bilateral, symmetric, nonprogressive hearing loss with rare inner ear malformations on radiologic imaging. Conclusions: These two patient populations have similar incidences in a cohort of patients evaluated for NSSNHL, which is higher than general population heterozygote carrier rates. Heterozygote mutation carriers had less hearing impairment, but most other factors demonstrated no differences. These results support the theory of an unidentified genetic factor contributing to hearing loss in some heterozygote carriers. Therefore, genetic counseling should consider the complexity of their genetic factors and the limitations of current screening.

KW - cochlear implant

KW - computed tomography

KW - Connexin 26

KW - connexin 30

KW - DFNB1

KW - GJB2

KW - GJB6

KW - molecular genetic testing.

KW - nonsyndromic sensorineural hearing loss

UR - http://www.scopus.com/inward/record.url?scp=79953101972&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953101972&partnerID=8YFLogxK

U2 - 10.1002/lary.21422

DO - 10.1002/lary.21422

M3 - Article

C2 - 21287563

AN - SCOPUS:79953101972

VL - 121

SP - 811

EP - 814

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

IS - 4

ER -